首页> 外文OA文献 >Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors

【2h】

Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors

机译：反对2型糖尿病的双靶系化合物：钠依赖性葡萄糖转运蛋白（SGLT）和糖原磷酸化酶（GP）抑制剂的概念证明

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ádám Sipos; Eszter Szennyes; Nikolett Éva Hajnal; Sándor Kun; Katalin E. Szabó; Karen Uray; László Somsák; Tibor Docsa; Éva Bokor;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i) [J] . Brunton Stephen, Rozjabek Heather M., Pilon Dominic, Current medical research and opinion . 2019,第9期

机译：糖尿病血红蛋白对治疗糖尿病患者（SGLT2）抑制剂2（SGLT2i）中的2型糖尿病患者的治疗增强和糖尿病血红蛋白目标达到的真实影响
2. Evidence-Based Clinical Review on Cardiovascular Benefits of SGLT2 (Sodium-Glucose Co-Transporter Type 2) Inhibitors in Type 2 Diabetes Mellitus [J] . Saad U. Rehman, Faiqa Rahman Cureus. . 2020,第8期

机译：基于证据的SGLT2（钠 - 葡萄糖共转运蛋白2）型糖尿病患者的心血管益处临床综述
3. Pharmacodynamics, Efficacy and Safety of Sodium-Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus [J] . Scheen Andre J. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2015,第1期

机译：钠-葡萄糖共转运蛋白2型（SGLT2）抑制剂治疗2型糖尿病的药效学，功效和安全性
4. Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes [C] . Joseph M. Hayes, Anastassia L. Kantsadi, Demetres D. Leonidas International Conference on Natural Products Utilization . 2014

机译：天然产物及其衍生物作为糖原磷酸化酶的抑制剂：2型糖尿病的潜在治疗
5. Mechanisms Underlying Cardiovascular Benefits of Sodium Glucose Co-transporter-2 Inhibitors: Myocardial Substrate or Sodium/Hydrogen Exchanger? [D] . Baker, Hana Elisabeth. 2020

机译：葡萄糖共转运蛋白-2抑制剂的心血管益处潜在的机制：心肌基质或钠/氢气交换器？
6. Clinical And Biochemical Outcomes Of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors In Type 2 Diabetes Mellitus Patients [O] . Muhammad Saleem, Nanik Ram, Sajjad Ali Khan, 2021

机译：糖尿病患者2型糖尿病患者的钠葡萄糖共转运蛋白-2（SGLT2）抑制剂的临床和生物化学结果
7. Current status of Sodium-Glucose Co-Transporter Type 2 (SGLT2) inhibitors in treating diabetes mellitus [O] . Motghare Vijay M, Ingale Nikita S, Turankar Avinash V, 2021

机译：钠葡萄糖共转运蛋白2（SGLT2）抑制剂治疗糖尿病的当前状态

Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅